Exploring Unmet Needs and Attitudes to Skin Self-examination in Melanoma Survivors

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04675346

Acronym

EUNASS

Enrollment

252

Registered

2020-12-19

Start date

2020-11-18

Completion date

2022-09-30

Last updated

2022-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma, Stage I, Melanoma, Stage II, Melanoma Stage III

Brief summary

This is a prospective, multi-centred cohort study whereby the EUNASS Study questionnaire will be administered electronically to identify needs of melanoma survivors, the extent to which these needs are being met, and identify areas which have the greatest need for development. It will also evaluate behaviour in relation to sun protection and skin self-examination (SSE). It will be a self-completed questionnaire. Qualitative work using semi-structured interviews will explore the needs of melanoma survivors in greater depth, will present examples of potential interventions to improve SSE and explore factors that determine the likelihood of engaging in an intervention which can address unmet needs, such as improving SSE. Taken together, the data will provide the evidence base to inform the development of an intervention to improve SSE, which can subsequently be tested in secondary care services.

Interventions

OTHERQuestionnaire

Questionnaire

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged 18 years or above. * Histological diagnosis of primary cutaneous invasive melanoma (any Breslow thickness) at 3 - 12 months from diagnosis (as most primary treatment will be complete by 3 mths) * American Joint Cancer Committee Version 8 \[2018\] (AJCC V8) Stage I - III melanoma at time of recruitment * Able to complete an electronic questionnaire

Exclusion criteria

* Other current active internal malignancy (i.e. does not include non-melanoma skin cancers) * Inability to independently complete electronic questionnaire * AJCC V8 Stage IV melanoma at time of recruitment * Clinical stage of disease unknown / unconfirmed

Design outcomes

Primary

Measure	Time frame	Description
Mixed methods: analysis of a) Patient questionnaire responses and b) Semi-structured interviews	2 years	Mixed methods analysis - quantitative and qualitative results

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026